"If we had had 800 (patients) already on that trial and PFS was the primary end point, it would have failed," says Lehman.
Holy cow....what a statement to make!!!
So Prima have $30m, a product that might be proven in 5+ years time after they spend.....what another $100 million??? Oh and the trial was designed to fail?????
Bizarre.
prr very much alive says matt lehman, page-2
Add IMM (ASX) to my watchlist
 (20min delay)
|
|||||
|
Last
36.5¢ |
Change
-0.015(3.95%) |
Mkt cap ! $530.2M | |||
| Open | High | Low | Value | Volume |
| 38.0¢ | 38.0¢ | 36.5¢ | $413.2K | 1.123M |
Buyers (Bids)
| No. | Vol. | Price($) |
|---|---|---|
| 2 | 103704 | 36.5¢ |
Sellers (Offers)
| Price($) | Vol. | No. |
|---|---|---|
| 37.0¢ | 68352 | 2 |
View Market Depth
| Last trade - 16.10pm 29/08/2024 (20 minute delay) ? |
| IMM (ASX) Chart |